Reduction of Intraoperative EEG Burst Suppression (BsR)

May 10, 2021 updated by: Technical University of Munich

Reduction of Intraoperative EEG Burst Suppression - Test of Efficacy

Burst suppression (BS) is a not physiological pattern in the electroencephalogram (EEG). BS during general anesthesia is mainly seen as a sign for too deep hypnosis and may increase the risk of postoperative delirium (POD), a disturbance of consciousness arising within 24 hours after surgery. This monocentric, simple masked randomized study aims primarily to investigate, whether particular anesthesiological interventions reduce the occurrence of intraoperative burst suppression. The investigator initiated trial includes 66 patients (male and female) aged ≥ 60 years in two groups (intervention and control group). Secondary aims will be the correlation of burst suppression and mean arterial pressure, concentration of anesthetics and postoperative delirium.

Study Overview

Detailed Description

Intraoperative burst suppression represents a non physiological EEG pattern. According to the literature and scientific knowledge, intraoperative burst suppression patterns might be caused either by hypotension resulting in a reduced cerebral circulation or by an oversedation of anesthetics correlating with a very deep level of hypnosis.

Some publications exist that discuss the occurrence of intraoperative burst suppression especially in elderly people (aged ≥ 60 years) as a predictor of postoperative delirium and postoperative cognitive dysfunction.

None of the studies however was able to prove a causal relationship between burst suppression and postoperative delirium. Contrary it might simply be an epiphenomenon.

Conducting this interventional trail primarily aims to prove whether specific anesthesiological interventions, such as the treatment of intraoperative hypotension in first line and/or the reduction of the concentration of anesthetics in second line, reduce intraoperative burst suppression. Hence it might be possible to investigate a possible casualty between burst suppression and postoperative delirium in a second trial.

Study Type

Interventional

Enrollment (Actual)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bayern
      • München, Bayern, Germany, 81675
        • Klinikum rechts der Isar - Klinik fuer Anaesthesiologie und Intensivmedizin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 60 years
  • Surgical interventions in general anesthesia (volatile or total intravenous anesthesia)
  • expected surgery duration ≥ 1h
  • American Society of Anesthesiologists (ASA) 1-4
  • written informed consent prior to study participation

Exclusion Criteria:

  • Neurological or psychiatric disorders
  • hearing difficulty
  • deafness
  • neurosurgical (intra)cranial surgery
  • pregnancy
  • expected continuous mandatory ventilation after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 1 - Blinded
EEG and Entropy will be blinded. The anesthesiological management will be performed by the anesthetist according to clinical standard operations.
Active Comparator: 2 - Unblinded
EEG and Entropy will be unblinded. The intervention starts with the start of a positive burst suppression rate. In the case of a concurrent hypotension the anesthetist treats the hypotension according to clinical standard operations in the first step. Hypotension means blood pressure values blow the baseline value which is defined by the lowest, preoperatively measured value. If after this treatment and a reevaluation of the BSR, BSR remains positive, the anesthetist is going to reduce the concentration of anesthetics in a second step. In case of positive BSR and a blood pressure value ≥ the baseline value, the concentration of anesthetics will be reduced as a first measure. The aim is to figure out whether one or both of these interventions can reduce to total, cumulative BSR.
The treatment of hypotension can be done by the responsible anesthetist according to the clinical standard operations including any accepted drug typically used in this hospital. The reduction of anesthetics can be done either by reducing the volatile end tidal anesthetics concentration (ETAC) or the infusion rate of propofol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chance of the total, cumulative burst suppression rate.
Time Frame: During general anesthesia and within the intervention
The total, cumulative burst suppression rate (BSR) corresponds to area under the curve and is defined by the BSR (%) and the absolute duration of BSR (t).
During general anesthesia and within the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burst suppression rate during induction.
Time Frame: During induction within the intervention
Rate of change of the burst suppression rate during induction.
During induction within the intervention
Burst suppression rate during maintenance.
Time Frame: During maintenance within the intervention
Rate of change of the burst suppression ratio during maintenance.
During maintenance within the intervention
Mean arterial blood pressure.
Time Frame: During burst suppression within general anesthesia
Evaluation of the mean arterial blood pressure with positive burst suppression rate.
During burst suppression within general anesthesia
Endtidal anesthetic concentration (ETAC) and infusion rate of propofol.
Time Frame: During burst suppression within the intervention
Evaluation of the mean ETAC and infusion rate of propofol.
During burst suppression within the intervention
Specific characteristics of the EEG frequency spectrum during burst suppression
Time Frame: During burst suppression within general anesthesia
Evaluation of specific EEG frequencies differentiating BSR caused by hypotension or oversedation of anesthetics.
During burst suppression within general anesthesia
Postoperative delirium.
Time Frame: Within the first three postoperative days
Screening of the patients regarding a postoperative delirium by a brief confession assessment method (bCAM).
Within the first three postoperative days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerhard Schneider, Prof. Dr., Clinic director - Department of anesthesiology and intensive care

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2019

Primary Completion (Actual)

December 19, 2020

Study Completion (Actual)

December 19, 2020

Study Registration Dates

First Submitted

November 22, 2018

First Submitted That Met QC Criteria

December 12, 2018

First Posted (Actual)

December 13, 2018

Study Record Updates

Last Update Posted (Actual)

May 11, 2021

Last Update Submitted That Met QC Criteria

May 10, 2021

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on Treatment of hypotension and/or reduction of anesthetics

3
Subscribe